The Molecular Diagnostics theme hosted a very successful seminar, ‘Advanced personalised therapies in gynaecological cancers’, at St Hugh’s College in February 2020. The meeting covered the genomics and immunology of cancer along with the emerging topic of advanced therapeutic medicinal products (ATMPs) in this setting. Speakers included Peter Cambell (Wellcome Sanger Institute) with a keynote lecture by James Brenton (CRUK Cambridge Institute), and co-chairs included Genomics England Clinical Interpretation Partnership – Endometrial Cancer Patient Representative, Helen White. The meeting was well attended by more than 100 delegates, including students, postdoctoral scientists, group leaders, physicians, surgeons and research nurses from Oxford University Hospitals NHS Foundation Trust.
The Vincenzo Cerundolo prize in Cancer Immunology was won by Rui Ma, for his presentation entitled ‘Playing hide and seek with glioblastoma: Using epigenetic modulators to increase cancer testis and neoantigen expression’. The panel discussions and questions were notable for their lively debate, and will hopefully serve as a catalyst for new collaborations and research projects within and outside this field.